Single nucleotide polymorphism of FCGR2A gene in Han Chinese children with Kawasaki disease

Chinese Journal of Contemporary Pediatrics

Volumn 15, Issue 3, 2013, Pages 196-200

  Ji, Yu Xiao ^a   Zhang, Hong Yan ^a   Lin, Shu Xiang ^a  

^a TIANJIN CHILDREN S HOSPITAL   (China)

Author keywords

Child; Coronary artery lesion; FCGR2A gene; Intravenous immunoglobulin; Kawasaki disease; Single nucleotide polymorphism

Indexed keywords

FCGR2A PROTEIN; IMMUNOGLOBULIN; PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CHILDHOOD DISEASE; CHINESE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG EFFICACY; DRUG RESPONSE; GENE FREQUENCY; GENE SEQUENCE; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; IMMUNOTHERAPY; MUCOCUTANEOUS LYMPH NODE SYNDROME; POLYMERASE CHAIN REACTION; RISK ASSESSMENT; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ASIAN CONTINENTAL ANCESTRY GROUP; CHILD; CHILD, PRESCHOOL; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INFANT; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, IGG;

EID: 84876138748     PISSN: 10088830     EISSN: None     Source Type: Journal    
DOI: 10.7499/j.issn.1008-8830.2013.03.008     Document Type: Article

References (21)

1. Wallace CA, French JW, Kahn SJ, Sherry DD. Initial intravenous gammaglobulin treatment failure in Kawasaki disease [J]. Pediatrics, 2000, 105(6): E78.
2. Kazatchkine MD, Kaveri SV. Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin [J]. N Engl Med, 2001, 345(10): 747-755.
3. Abe J, Jibiki T, Noma S, Nakajima T, Saito H, Terai M. Gene expression profiling of the effect of high-dose intravenous Ig in patients with Kawasaki disease [J]. J Immunol, 2005, 174 (9) : 5837-5845.
4. Taniuchi S, Masuda M, Teraguchi M, Ikemoto Y, Komiyama Y, Takahashi H, et al. Polymorphism of fcgamma riia may affect the efficacy of gamma-globulin therapy in Kawasaki disease [J]. Clin Immunol, 2005, 25(4) :309-313.
5. Biezeveld M, Geissler J, Merkus M, Kuipers IM, Ottenkamp J, Kuijpers T. The involvement of fc gamma receptor gene polymorphisms in kawasaki disease [J]. Clin Exp Immunol, 2006, 147 (1): 106-111.
6. Khor CC, Davila S, Breunis WB, Lee YC, Shimizu C, Wright VJ, et al. Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease[J]. Nat Genet, 2011, 43 (12): 1241-1246.
7. Lee YC, Kuo HC, Chang JS, Chang LY, Huang LM, Chen MR, et al. Two new susceptibility loci for Kawasaki disease identified through genome-wide association analysis [J]. Nat Genet, 2012, 44(5): 522-525
8. Onouchi Y, Ozaki K, Burns JC, Shimizu C, Terai M, Hamada H, et al. A genome-wide association study identifies three new risk loci for Kawasaki disease [J]. Nat Genet, 2012, 44 (5) ; 517-521.
9. Shrestha S, Wiener H, Shendre A, Kaslow RA, Wu J, Olson A, et al. Role of activating FcyR gene polymorphisms in Kawasaki disease susceptibility and intravenous immunoglobulin response [J]. Circ Cardiovasc Genet, 2012, 5(3): 309-316.
10. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis,treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young. American Heart Association [J]. Pediatrics, 2004, 114(6): 1708-1733.
11. Ayusawa M, Sonobe T, UemuraS, OgawaS, NakamuraY, Kiyosawa N, et al. Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition) [J]. Pediatr Int, 2005, 47(2): 232-234.
12. van de Winkel JG, Anderson CL. Biology of human immunoglobulin G Fc receptors[J]. Leukoc Biol, 1991, 49(5): 511-524.
13. Sinha S, Prasad KN, Jain D, Nyati KK, Pradhan S, Agrawal S. Immunoglobulin IgG Fc-receptor polymorphisms and HLA class II molecules in Guillain-Barre syndrome [J]. Acta Neurol Scand, 2010, 122(1): 21-26.
14. Meziani R, Yamada R, Takahashi M, Ohigashi K, Morinobu A, Terao C, et al. A trans-ethnic genetic study of rheumatoid arthritis identified FCGR2A as a candidate common risk factor in Japanese and European populations[J]. Mod Rheumatol, 2012, 22 (1); 52-58.
15. YangSK, JungY, KimH, HongM, Ye BD, Song K. Association of FCGR2A, JAK2 or HNF4A variants with ulcerative colitis in Koreans [J]. Dig Liver Dis, 2011, 43(11): 856-861.
16. Gordon JB, Kahn AM, Burns JC. When children with Kawasaki disease grow up; Myocardial and vascular complications in adulthood [J]. Am Coll Cardiol, 2009, 54(21): 1911-1920.
17. Tsujimoto H, Takeshita S, Nakatani K, Kawamura Y, Tokutomi T, Sekine I. Intravenous immunoglobulin therapy induces neutrophil apoptosis in Kawasaki disease [J]. Clin Immunol, 2002, 103 (2): 161-168.
18. Hui-Yuen JS, Duong TT, Yeung RS. TNF-alpha is necessary for induction of coronary artery inflammation and aneurysm formation in an animal model of Kawasaki disease [J]. J Immunol, 2006, 176(10): 6294-6301.
19. Burns JC, Best BM, Mejias A, Mahony L, Fixler DE, Jafri HS, et al. Infliximab treatment of intravenous immunoglobulin-resistant Kawasaki disease[J]. J Pediatr, 2008, 153(6): 833-838.
20. Son MB, Gauvreau K, Burns JC, Corinaldesi E, Tremoulet AH, Watson VE, et al. Infliximab for intravenous immunoglobulin resistance in Kawasaki disease; a retrospective study [J]. J Pediatr, 2011, 158(4): 644-649.
21. Onouchi Y. Molecular genetics of Kawasaki disease [J]. Pediatr Res, 2009, 65(5 Pt 2): 46R-54R.